Tadvalkar Laura 4
4 · Cidara Therapeutics, Inc. · Filed Apr 30, 2024
Insider Transaction Report
Form 4
Tadvalkar Laura
Director
Transactions
- Award
Stock Option (right to buy)
2024-04-26+4,250→ 4,250 totalExercise: $12.63Exp: 2034-04-25→ Common Stock (4,250 underlying)
Footnotes (2)
- [F1]1/3rd of the total number of shares subject to the award shall vest on April 26, 2025 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on April 26, 2027.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.